In-depth mechanism of action reviews for individual research peptides.
Tesamorelin is a 44-amino acid synthetic analog of endogenous growth hormone-releasing hormone (GHRH) that incorporates a trans-3-hexenoic acid modification at
GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) that has emerged as one of the most extensively studied regenerative peptides
Semaglutide peptide research centres on a long-acting GLP-1 receptor agonist whose C-18 fatty diacid chain and amino acid substitutions confer
Combined CJC-1295 and ipamorelin administration produces six- to ten-fold greater growth hormone release than either peptide alone through simultaneous GHRH-R and GHS-R1a activation. This review examines the molecular basis of dual-pathway somatotroph synergy, pharmacokinetic considerations, and current preclinical evidence.
Comprehensive review of BPC-157 pentadecapeptide research mechanisms including nitric oxide system modulation, VEGFR2-mediated angiogenesis, growth hormone receptor upregulation, GAP-43 neuroprotective pathways, and translational evidence from over 500 published preclinical studies.
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic tuftsin-derived heptapeptide that modulates anxiolytic and immunoregulatory pathways through indirect GABAergic allosteric modulation, BDNF upregulation,
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide that activates melanocortin-3 and melanocortin-4 receptors (MC3R/MC4R) in hypothalamic neurons, representing the only
SS-31 (elamipretide) is a mitochondria-targeted tetrapeptide that has emerged as one of the most studied compounds in mitochondrial medicine research.
Comprehensive research review of CJC-1295, a tetrasubstituted GHRH(1-29) analog with DPP-IV resistance. Covers albumin bioconjugation via DAC modification, GHRH receptor signaling, GH/IGF-1 axis preclinical evidence, and variant selection for research applications.
LL-37 peptide research centres on the only cathelicidin-derived antimicrobial peptide produced in humans, a 37-residue amphipathic alpha-helix cleaved from the
Canadian supplier of high-purity research compounds for laboratory and scientific applications.
BC Facility, British Columbia, Canada
[email protected]That is the third-party report for the BPC-157 10MG on the shelf right now. Every vial ships against a batch report you can open yourself. Add your email and your first-order code appears right here.
For research purposes only. Not for human consumption. Not for diagnostic or therapeutic use. Sold to qualified researchers 18+.
Maple